Home » Newsletters » BioWorld Science

BioWorld Science

July 16, 2015

View Archived Issues

Dendritic cell vaccination induces tumor-specific immune responses

China Food and Drug Administration accepts clinical trial application for sirotinib

ONO-7750512 shows potent antithrombotic effect without increasing bleeding risk

Bristol-Myers Squibb provides update on pipeline for fibrotic diseases

Aerpio Therapeutics reports data from phase IIa study of AKB-9778 in DME

CytoDyn reports evidence of HIV suppression with PRO-140

Pharmacological profile a novel FXIa inhibitor from Sumitomo Dainippon presented

Initiation of phase II study of Ad26.ZEBOV and MVA-BN-Filo Ebola prime-boost vaccine regimen

Esteve discloses sigma1-receptor ligands

Wee1-like protein kinase inhibitors in early development at Almac Discovery

A*STAR patent describes Wnt signaling inhibitors

BTK inhibitors described in Merck & Co. patent

IRM divulges antiparasitic agents

Santen launches Ikervis in Germany for keratitis in dry eye disease

FDA grants orphan drug designation to DPX-Survivac for ovarian cancer

ValiRx announces plans for phase II trial of VAL-401

Treeway and collaborators receive grant to develop edaravone for ALS

Nanocarrier formulation improves delivery of CsA to the eye

FDA gives orphan drug designation to Kevetrin for ovarian cancer

AB Science initiates phase II/III trial of masitinib in ovarian cancer

Cerenis releases results from LOCATION study of CER-001 in atherosclerotic disease

AstraZeneca enters into commercialization option agreement for benralizumab in Japan

Celgene to acquire Receptos

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

Swedish Orphan Biovitrum exercises Alprolix opt-in right

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...